Bill Snyder Archive — Page 53 of 121
-
February 6, 2020
Nobel Prize-winning biochemist Stanley Cohen dies at 97
Vanderbilt University biochemist Stanley Cohen, PhD, whose discovery of epidermal growth factor (EGF) and its receptor earned him a Nobel Prize and opened the door to a new class of cancer therapies, died Wednesday, Feb. 5, in Nashville. He was 97. -
February 5, 2020
Vaccine Program receives NIH renewal of VTEU
The Vanderbilt Vaccine Research Program has received a grant from the NIH to continue its work as one of the nation’s nine Vaccine and Treatment Evaluation Units. -
January 29, 2020
Protein research seeks to induce tumor regression
Understanding how MYC interacts with WDR5 and other cofactors could lead to the development of new drugs that can effectively block MYC and stop many cancers in their tracks. -
January 23, 2020
Vaccine Program receives NIH renewal of VTEU
The Vanderbilt Vaccine Research Program (VVRP) has received a grant from the National Institutes of Health (NIH) to continue its work as one of the nation’s nine Vaccine and Treatment Evaluation Units (VTEUs). -
January 23, 2020
Antibody isolated at VUMC found to halt dengue virus
Using part of an antibody isolated at Vanderbilt that “broadly neutralizes” the human dengue virus, biologists at the University of California San Diego and colleagues have disarmed the mosquito that transmits the disabling and potentially deadly tropical infection. -
January 16, 2020
VUMC study sheds light on gastric cancer development
VUMC researchers have created the world’s first laboratory model of precancerous changes in the lining of the stomach, a scientific tour de force that is helping to unlock the mysteries of gastric cancer development.